Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma

Autophagy

Volumn 8, Issue 2, 2012, Pages 275-277

  Huang, Jun ^a,b   Liu, Ke ^a,b   Yu, Yan ^a,c   Xie, Min ^a,c   Kang, Rui ^a,c,d   Vernon, Philip ^d   Cao, Lizhi ^a,c   Tang, Daolin ^d   Ni, Jiangdong ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Autophagy; Chemotherapy; HMGB1; Osteosarcoma

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ARSENIC TRIOXIDE; BECLIN 1; CISPLATIN; CYCLOHEXIMIDE; CYTARABINE; DOXORUBICIN; GEMCITABINE; HIGH MOBILITY GROUP B1 PROTEIN; KRUPPEL LIKE FACTOR 4; MELPHALAN; MESSENGER RNA; METHOTREXATE; PACLITAXEL; PROTEIN P53; RAPAMYCIN; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR; VINCRISTINE; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER RESISTANCE; CELL SURVIVAL; DNA BINDING; DNA REPLICATION; DRUG SENSITIVITY; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HOMEOSTASIS; HUMAN; LUNG METASTASIS; METABOLIC STRESS; MITOPHAGY; MULTIPLE CANCER; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PROTEIN TARGETING; TREATMENT OUTCOME; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; HMGB1 PROTEIN; HUMANS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; OSTEOSARCOMA; UP-REGULATION;

EID: 85046981421     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.8.2.18940     Document Type: Article

References (0)